# 2/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research

> **NIH NIH U54** · DANA-FARBER CANCER INST · 2021 · $1,833,005

## Abstract

SUMMARY
The University of Massachusetts Boston (UMass Boston) and Dana-Farber/Harvard Cancer Center (DF/HCC)
Partnership is primed for “Bridging the Divides: Innovations to Address Gaps in Cancer Disparities
Research, Education, Outreach and Infrastructure.” Our goal is to pursue Partnership activities and
research that will bridge the divides in cancer disparities science, research education, and outreach through
innovative research, training, and practice, serving as models for translation at the state and national level. The
Partnerships to Advance Cancer Health Equity (PACHE) program itself is a prime example of bridged divides:
partnerships formed between institutions have enhanced the education of underrepresented population groups
and provided well-established cancer centers with the necessary resources and research infrastructure to
address cancer disparities.
The specific aims of the UMass Boston–DF/HCC Partnership are to: 1) Advance Partnership transdisciplinary
cancer and cancer health disparities research programs reflecting the theme “Bridging the Divides”; 2) Develop
educational experiences for students and trainees from a diverse population typically underrepresented in
biomedical careers; 3) Promote hiring and retention of diverse scholars, particularly those from
underrepresented populations, by leveraging institutional resources; 4) Bridge research-community divides
through innovative platforms: forming and engaging networks of community-based organizations to advance
outreach drawing on state of the science from dissemination and implementation sciences (D&I); 5) Develop
cutting-edge approaches to address data-absenteeism, the lack of representation of underserved groups in
population-, community-, and genomics-based cancer and cancer disparities datasets and projects; and 6)
Promote sustainability of partnership activities by reinforcing institutional support and grant matching with NIH-
mechanisms and other sources of government, foundation, and philanthropic support.

## Key facts

- **NIH application ID:** 10328008
- **Project number:** 2U54CA156732-11
- **Recipient organization:** DANA-FARBER CANCER INST
- **Principal Investigator:** Gregory Alan Abel
- **Activity code:** U54 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $1,833,005
- **Award type:** 2
- **Project period:** 2010-09-27 → 2026-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10328008

## Citation

> US National Institutes of Health, RePORTER application 10328008, 2/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research (2U54CA156732-11). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10328008. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*